Detrimental effects of conflicts of interest in GLP-1 therapy guidance

BMJ 2026

View at publisher
Authors: Arnav Agarwal, Per Olav Vandvik, Nicolas Delvaux, Thomas Agoritsas
DOI: 10.1136/bmj-2026-527061
Cited by: 1
References: 20

Abstract

sponsorship: Competing interests: AA, POV, ND, and TA are methodologists with the MAGIC Evidence Ecosystem Foundation and co-lead the BMJ Rapid Recommendations series in partnership with The BMJ . They are leading guideline development efforts fora living practice guideline on medications for type 2 diabetes and a new guideline on medications for overweight and obesity. The authors have no financial or other conflicts to disclose. (MAGIC Evidence Ecosystem Foundation)

Fields of Study & Subjects

Pharmaceutical industry and healthcare Diabetes Treatment and Management Medication Adherence and Compliance

Publication details

Journal / source
BMJ
Publisher
BMJ
Volume
393
Pages
e527061–e527061
Publication date
19 June 2026
Language
EN